5Melanson SE, Lewandrowski EL. Laboratory testing for B-type natri- uretic peptides (BNP and NT-proBNP) : clinical usefulness, utiliza- tion, and impact on hospital operations [ J ]. Am J Clin Pathol, 2005,124 (suppl) :s122-128.
7Kemperman H, van den Berg M, Kirkels H, et al. B-type natriuret- ic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device [ J ]. Clin Chem, 2004,50(9) :1670-1672.
8Wieczorek S J, Wu AH, Christenson R, et al. A rapid B-type natri- uretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure : a multicenter evaluation [ J ]. Am Heart J, 2002, 144 (5) : 834-839.
9Gegenhuber A, Mueller T, Firlinger F, et al. Time course of B- type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure [ J ]. Clin Chem, 2004,50 (2) :454-456.
3Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult:a report of the American Colege of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure):developed in collaboration with the American Colege of Chest Physicians and the International Society for Heart and Lung Transplantation:endorsed by the Heart Rhythm Society[J].Circulation,2005,112 (12):155-235.
4Kapoun AM,Liang F,O 'Young G,et al.B2 Type natriu retic peptide exert s broad functional opposition to transforming growth fact or-in primary human cardiac fib roblasts[J].Circulation Research,2004,94(4):453.
5Kenneth D,Alain CS,G erasimos F,et al.ESC Guidelines for the diagnosis and treatment of acute andchronic heart failure 2008[J].European Heart Journal,2008,89 (6):173-180.
